Ignite Creation Date:
2024-05-05 @ 5:16 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00421369
Status:
COMPLETED
Last Update Posted:
2013-03-22
First Post:
2007-01-11
Brief Title:
Augmentation of the Antidepressant Action of Sertraline With Triiodothyronine T3and Reboxetine Clinical Efficacy Adverse Effects and Predictors of Response
Sponsor:
Organization:
Hadassah Medical Organization
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
35
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| NA |
Observational Models:
Time Perspective List:
Who Masked List: